Phenox

About Phenox

Phenox, founded in 2005, specializes in developing innovative and clinically proven technologies for treating neurovascular diseases. The company serves endovascular specialists who treat ischemic and hemorrhagic strokes. Operating in the medical device market, Phenox offers a portfolio of advanced treatment options, including aneurysm implants and flow diverter coatings designed to reduce thrombosis risk. The business model revolves around the sale of these specialized medical devices, generating revenue through direct sales and partnerships. Phenox is committed to expanding its global reach, making its cutting-edge solutions accessible to more patients worldwide.